NM_005633.4:c.-15C>T
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting
The NM_005633.4(SOS1):c.-15C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000382 in 1,570,600 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005633.4 5_prime_UTR
Scores
Clinical Significance
Conservation
Publications
- Noonan syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Noonan syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- fibromatosis, gingival, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- hereditary gingival fibromatosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- cardiofaciocutaneous syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- Costello syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151882Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000503 AC: 1AN: 198922 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000141 AC: 2AN: 1418718Hom.: 0 Cov.: 31 AF XY: 0.00000142 AC XY: 1AN XY: 705466 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151882Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74192 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The -15C>T variant in SOS1 has not been previously reported in our laboratory or in the literature. The frequency of this variant in large European American and African American populations cannot be determined from the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS) because coverage at this position was insufficient. This variant is located in the 5' untranslated region (5' UTR) and does not affect the coding sequence of the gene. Although we cannot rule ou t a deleterious impact on the regulation of splicing or translation of SOS1, to date no pathogenic variants have been found in this region of the transcript. In summary, additional studies are needed to determine the clinical significance o f the -15C>T variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at